"
The Influence of Pyrazinamide Monoresistance on Treatment Outcomes in Tuberculosis Patients from Southern China"
written by Shouyong Tan, Yunwei Rao, Jintao Guo, Yaoju Tan, Xingshan Cai, Haobin Kuang, Yanqiong Li, Wenyan Liu, Julius Mugweru, Bangxing Wang, Yuanyuan Cao, Changwei Wang, Ying Zhang, Tianyu Zhang,
published by
Journal of Tuberculosis Research,
Vol.4 No.1, 2016
has been cited by the following article(s):
|
[1]
|
Insights from the molecular mechanism of pyrazinamide to mutated pyrazinamidase linked to the
pncA
gene in clinical isolates of
Mycobacterium tuberculosis
Journal of Biomolecular Structure and Dynamics,
2024
DOI:10.1080/07391102.2023.2195002
|
|
|
|
|
[2]
|
Insights from the molecular mechanism of pyrazinamide to mutated pyrazinamidase linked to the pncA gene in clinical isolates of Mycobacterium tuberculosis
Journal of Biomolecular Structure and Dynamics,
2023
DOI:10.1080/07391102.2023.2195002
|
|
|
|
|
[3]
|
A Case of Pulmonary Tuberculosis with Initial PZA Monoresistance Associated with Total Deletion of the pncA Gene
Kansenshogaku Zasshi,
2021
DOI:10.11150/kansenshogakuzasshi.95.343
|
|
|
|
|
[4]
|
Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia
Journal of Global Antimicrobial Resistance,
2019
DOI:10.1016/j.jgar.2018.08.018
|
|
|
|
|
[5]
|
Diagnostic Molecular Mycobacteriology in Regions With Low Tuberculosis Endemicity: Combining Real-time PCR Assays for Detection of Multiple Mycobacterial Pathogens With Line Probe Assays for Identification of Resistance Mutations
EBioMedicine,
2016
DOI:10.1016/j.ebiom.2016.06.016
|
|
|
|